• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HMI
Click for more information
0.00% 5.7¢

HIREMII LIMITED - Corporate Spotlight

Market Cap $7.682M  ! watchlist Created with Sketch. Add to my watchlist
Industrials

Hiremii Limited is an Australia-based company, which is engaged in the technology driven... Hiremii Limited is an Australia-based company, which is engaged in the technology driven full-service labor hire and recruitment services. The Company has two business components, such as Hiremii Technology and Inverse Group Pty Ltd (Inverse Group). Hiremii Technology is a cloud-based platform, which uses machine learning and artificial intelligence to remove the tedious manual tasks associated with the recruitment and onboarding process, pre-vetting and shortlisting candidates based on the employer specific requirements. The Inverse Group is a recruitment business that provides specialist white collar recruitment services to the energy, resources, and technology sectors. It is developing a shortlisting tool that matches candidates on its cloud-based platform. Utilizing artificial intelligence (AI) technology, it can parse candidate curriculum vitae (CVs) and match the candidate against a client's job scope.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
5.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $7.682M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 182979 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 15000 1
View Market Depth
Last trade - 10.04am 02/10/2024 (20 minute delay) ?
HMI (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.